Effect of Astragali Radix in improving early renal damage in metabolic syndrome rats through ACE2/Mas pathway.
- Author:
Qiong-ying WANG
;
Wei LIANG
;
Cheng JIANG
;
Ning-yin LI
;
Han XU
;
Mi-na YANG
;
Xin LIN
;
Heng YU
;
Peng CHANG
;
Jing YU
- Publication Type:Journal Article
- MeSH:
Angiotensin I;
metabolism;
Animals;
Astragalus Plant;
chemistry;
Blood Glucose;
metabolism;
Blood Pressure;
drug effects;
Drugs, Chinese Herbal;
administration & dosage;
Humans;
Kidney;
drug effects;
injuries;
metabolism;
Male;
Malondialdehyde;
metabolism;
Metabolic Syndrome;
drug therapy;
genetics;
metabolism;
physiopathology;
Peptide Fragments;
metabolism;
Peptidyl-Dipeptidase A;
genetics;
metabolism;
Proto-Oncogene Proteins;
genetics;
metabolism;
Rats;
Rats, Sprague-Dawley;
Receptors, G-Protein-Coupled;
genetics;
metabolism;
Signal Transduction;
drug effects
- From:
China Journal of Chinese Materia Medica
2015;40(21):4245-4250
- CountryChina
- Language:Chinese
-
Abstract:
To study the expression of angiotensin converting enzyme 2 (ACE2) and angiotensin (Ang) 1-7 specific receptor Mas protain in renal blood vessels of metabolic syndrome ( MS) rats and its anti-oxidative effect. A total of 80 male SD rats were divided into four groups: the normal control group (NC, the same volume of normal saline), the MS group (high fat diet), the MS + Astragali Radix group (MS + HQ, 6 g x kg(-1) x d(-1) in gavage) and the MS + Valsartan group (MS + XST, 30 mg x kg(-1) x d(-1) in gavage). After four weeks of intervention, their general indexes, biochemical indexes and blood pressure were measured; plasma and renal tissue Ang II, malondialdehyde (MDA) and superoxide demutase (SOD) levels were measured with radioimmunoassay. The protein expressions of Mas receptor, AT1R, ACE and ACE2 were detected by western blot analysis. According to the result, compared with the NC group, the MS group and the MS + HQ group showed significant increases in systolic and diastolic pressures, body weight, fasting glucose, fasting insulin, triglycerides, free fatty acid and Ang II level of MS rats (P < 0.05). The MS + XST group showed notable decreases in systolic and diastolic pressures than that of the MS group. The MS group showed significant increases in the SOD activity and NO level and decrease in the MDA level after being intervened with Astragali Radix. ACE and AT1R protein expressions in renal tissues of the MS group were higher than that in the NC group, but with lower ACE2 and -Mas receptor expressions (all P < 0.05). Compared with the MS group, the MS + HQ group showed significant increase in Mas receptor expression in renal tissues, whereas the MS + XST group showed notable decrease in AT1R (all P < 0.05). In conclusion, Astragali Radix can increase the Mas receptor expressions in renal tissues, decrease ACE expression and change local Ang II, MDA, NO and SOD in kidneys, so as to protect early damages in renal tissues.
